Form DEFA14A CROWN CASTLE INC.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy... (continue reading...)
Form 6-K ELTEK LTD For: May 13
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission file number 000-28884
Eltek Ltd.
(Name of Registrant)
Sgoola Industrial... (continue reading...)
Form 8-K Akoustis Technologies, For: May 13
false
0001584754
0001584754
2024-05-13
2024-05-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the... (continue reading...)
Form 8-K Milestone Pharmaceutical For: May 13
false
0001408443
A8
00-0000000
QC
0001408443
2024-05-13
2024-05-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to... (continue reading...)
Form 20-F Ferroglobe PLC For: Dec 31
http://archive.fast-edgar.com/20240513/AQZ2AG2CZ222BZ8Z2B2D2ZZ2NDJATM2IZ262
Filed on: May 13, 2024
More SEC Filings
View Older Stories-
Form 10-Q Avalo Therapeutics, Inc. For: Mar 31
-
Form 8-K NET Power Inc. For: May 13
-
Form 10-Q RAND CAPITAL CORP For: Mar 31
-
Form 13F-HR Regal Partners Ltd For: Mar 31
-
Form 13F-HR Tredje AP-fonden For: Mar 31
-
Form 10-Q Quince Therapeutics, For: Mar 31
-
Form 10-Q Iterum Therapeutics plc For: Mar 31
-
Form 8-K Avalo Therapeutics, Inc. For: May 13
-
Form 10-Q Galera Therapeutics, For: Mar 31
-
Form 10-Q TScan Therapeutics, Inc. For: Mar 31
-
Form 8-K Moleculin Biotech, Inc. For: May 13
-
Form 6-K LITHIUM AMERICAS CORP. For: May 13
-
Form S-8 Apogee Therapeutics,
-
Form 13F-NT Viola Growth Management For: Mar 31
-
Form 8-K BOYD GAMING CORP For: May 09
-
Form 13F-NT Viola Ventures GP 3 Ltd. For: Mar 31
-
Form 8-K Autolus Therapeutics For: May 13
-
Form 8-K AVANOS MEDICAL, INC. For: May 13
-
Form 13F-HR Dunhill Financial, LLC For: Mar 31
-
Form 13F-HR Viola Ventures V.C. Mana For: Mar 31
-
Form SC TO-C INCYTE CORP Filed by: INCYTE CORP
-
Form 13F-HR Handelsbanken Fonder AB For: Mar 31
-
Form 6-K Gildan Activewear Inc. For: May 13
-
Form 8-K INCYTE CORP For: May 12
-
Form 10-Q Akoustis Technologies, For: Mar 31
-
Form 10-Q PRECISION BIOSCIENCES For: Mar 31
-
Form 10-Q Fulcrum Therapeutics, For: Mar 31
-
Form 8-K ProPetro Holding Corp. For: May 09
-
Form 8-K TScan Therapeutics, Inc. For: May 13
-
Form 8-K Tourmaline Bio, Inc. For: May 13
-
Form 8-K PRECISION BIOSCIENCES For: May 13
-
Form 8-K Iterum Therapeutics plc For: May 13
-
Form 10-Q/A CareMax, Inc. For: Mar 31
-
Form 6-K Sendas Distributor S.A. For: Jun 30
-
Form 10-Q Apogee Therapeutics, For: Mar 31
-
Form 8-K LEAP THERAPEUTICS, INC. For: May 13
-
Form 8-K MITEK SYSTEMS INC For: May 09
-
Form S-1/A Bowhead Specialty Holdin
-
Form 13F-HR LOGAN CAPITAL MANAGEMENT For: Mar 31
-
Form 10-Q Boundless Bio, Inc. For: Mar 31
-
Form 8-K Apogee Therapeutics, For: May 13
-
Form 8-K Galera Therapeutics, For: May 13
-
Form 8-K Boundless Bio, Inc. For: May 13
-
Form 8-K Fulcrum Therapeutics, For: May 11
-
Form 8-K D-Wave Quantum Inc. For: May 13
-
Form 8-K Veradigm Inc. For: May 10
-
Form 6-K Can-Fite BioPharma Ltd. For: May 13
-
Form 8-K Squarespace, Inc. For: May 13
-
Form 10-Q/A NextDecade Corp. For: Mar 31
-
Form D Amet LLC
